Congratulations! VALOR Animal Pharmaceuticals and the Brazil Belt and Road Cultural and Economic Development Fund Federation signed a strategic cooperation agreement.
In 2018, a delegation of 10 people, including Ji Youyi, founder of the Brazil Belt and Road Cultural and Development Foundation, Jia Yuanchun, secretary-general, Li Yong, inspector of the Chongqing Municipal Government Foreign Affairs Office, Wang Yufei of the Chongqing Municipal Government Belt and Road Office, and other Brazilian representatives, visited VALOR Animal Pharmaceuticals. The vice general manager and sales director, along with heads of relevant departments, warmly received them and expressed a heartfelt welcome to the overseas clients.
At the meeting, the company’s Vice General Manager and Sales Director introduced Fangtong’s international business layout, advantageous products, and capabilities in manufacturing, R&D innovation, and supply chain security. He also emphasized the company’s business philosophy, technological strength, product quality, and technological level. Ji Youyi, founder of the Brazil Belt and Road Culture and Development Foundation, Jia Yuanchun, Secretary-General, and Brazilian representatives introduced Brazil’s national conditions, animal health market, breeding structure, market demand, and the foundation’s work in promoting friendly exchanges between China and Brazil, facilitating economic and trade cooperation, and supporting Chinese enterprises going global. Both sides conducted in-depth exchanges and communication on cooperation directions. The Brazilian representatives highly praised Fangtong Animal Pharmaceutical’s development achievements, fully affirmed the excellent quality, significant efficacy, and good reputation of VALOR’s products in overseas markets, and expressed a positive willingness to deepen cooperation on more product varieties.
Following the meeting, a delegation of experts from the Brazil Belt and Road Cultural and Development Foundation, accompanied by company personnel, toured VALOR Animal Pharmaceuticals’ production workshops, water treatment workshops, and intelligent warehousing and supply chain management areas. The client listened attentively to detailed presentations from those responsible for each stage regarding process flow, quality control, equipment automation levels, and GMP compliance management. They also engaged in on-site discussions regarding key technical parameters and production details. Through the site visit, the client highly praised VALOR Animal Pharmaceuticals’ professional capabilities in R&D innovation, intelligent manufacturing, comprehensive quality control, and the construction of high-standard systems. They particularly commended the company’s pragmatic measures in strictly adhering to international standards and continuously improving product quality. This visit further strengthened the client’s confidence in deepening cooperation and laid a solid foundation for future collaborations on more high-value-added products.
Back in the conference room, representatives from both sides, adhering to the principles of mutual benefit, win-win cooperation, and coordinated development, signed the “Strategic Cooperation Agreement,” marking a new stage and the beginning of a new journey in their cooperative relationship. This signing not only fully affirms the positive progress of their cooperation but also represents a solemn commitment to deepening collaboration and jointly pursuing development in the future, laying a solid foundation and creating favorable conditions for further pragmatic cooperation.
Building upon its continuously strengthened R&D innovation and intelligent manufacturing capabilities, VALOR Animal Pharmaceuticals is steadily advancing its international strategic layout. It has successively established R&D centers and representative offices overseas, continuously expanding its global service network and significantly enhancing its comprehensive service capabilities and responsiveness in the international market, thereby continuously strengthening its global competitiveness. Currently, the company’s products are exported to many countries and regions in Europe, the Middle East, Africa, South America, and Southeast Asia. With stable and reliable quality, good clinical efficacy, and standardized production management, VALOR practices the corporate spirit of “Fangtong Creates Excellence, Innovation Leads to Brilliance,” adhering to its original commitment to quality, deeply cultivating the animal health field, and actively serving human health. With a professional, efficient, and responsible attitude, VALOR contributes to promoting high-quality development of the industry and enhancing global customer value.
